We are live on ! Find out more
ACIU icon

AC Immune
ACIU

17 hedge funds and large institutions have $90.4M invested in AC Immune in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.35% less ownership

Funds ownership: 18.41% → 18.06% (-0.35%)

6% less funds holding

Funds holding: 18 → 17 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

17% less capital invested

Capital invested by funds: $109M → $90.4M (-$18.4M)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LBC
Lawrence B. Cohen
+$312K
2
Renaissance Technologies
Renaissance Technologies
New York
+$186K
3
Goldman Sachs
Goldman Sachs
New York
+$134K
4
Deutsche Bank
Deutsche Bank
Germany
+$128K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$58.5K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.27M
2
GCP
GSA Capital Partners
United Kingdom
-$525K
3
AA
ALPS Advisors
Colorado
-$485K
4
Citadel Advisors
Citadel Advisors
Florida
-$325K
5
Victory Capital Management
Victory Capital Management
Texas
-$277K

ACIU Hedge Fund Activity: Q2 2017 in Review

17 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2017, worth a combined $90.4M — down 17% from $109M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ACIU and 6 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.

The largest buyer was Lawrence B. Cohen, opening a new position worth an estimated $312K. The largest seller was Millennium Management, exiting entirely with an estimated $1.27M sold.

  • 17 institutional investors held AC Immune (ACIU) as of Q2 2017, down from 18 in Q1 2017.
  • Funds reported $90.4M of AC Immune stock for Q2 2017, down 17% quarter-over-quarter.
  • 6 funds opened new AC Immune positions in Q2 2017 and 7 closed out, a net change of -1 holder.
  • The largest AC Immune buyer in Q2 2017 was Lawrence B. Cohen, an estimated $312K added.
  • The largest AC Immune seller in Q2 2017 was Millennium Management, an estimated $1.27M sold.

Based on aggregated 13F filings for Q2 2017.